Role of Endogenous Adenosine as a Modulator of Syncope Induced During Tilt Testing
- 30 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (5) , 569-574
- https://doi.org/10.1161/01.cir.0000023924.66889.4c
Abstract
Background — Previous reports that used head-up tilt testing and adenosine administration have suggested that adenosine may be an important endogenous mediator that may trigger a vasovagal response in susceptible patients. However, little is known regarding endogenous adenosine plasma levels (APLs) during vasovagal syncope provoked by tilt testing. The aim of this study was to determine whether APLs differ in patients with a positive head-up tilt test compared with those with a negative test and whether APLs are modified during tilt-induced vasovagal syncope. Methods and Results — APLs (mean±SEM) were measured during head-up tilt test in 26 patients who presented with unexplained syncope. In the 15 patients with a negative test, APLs were 0.39±0.03 μmol/L at baseline, 0.22±0.03 μmol/L immediately after tilting, and 0.44±0.03 μmol/L after 45 minutes. APLs were significantly higher in the 11 patients with a positive test (2.66±0.67 μmol/L at baseline and 3.22±0.85 μmol/L immediately after tilting) than in those with a negative test. During tilt testing–induced syncope, APLs increased to reach 4.03±0.66 μmol/L (ie, a 52% increase compared with baseline levels; P Conclusions — This study showed that APLs were higher in patients with a positive tilt test than in patients with a negative test and that they increased during tilt testing–induced syncope. These observations suggest that adenosine release may be involved in the triggering mechanism of syncope induced during tilt testing.Keywords
This publication has 18 references indexed in Scilit:
- Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncopeHeart, 2000
- Indications, methodology, and classification of results of tilt-table testingThe American Journal of Cardiology, 1999
- Adenosine: Potential modulator for vasovagal syncopeJournal of the American College of Cardiology, 1996
- Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y‐ and facilitatory A2A‐purinoceptorsBritish Journal of Pharmacology, 1996
- Contribution of P1 (A2b subtype) and P2‐purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bedBritish Journal of Pharmacology, 1995
- Co-release of noradrenaline and ATP from cultured sympathetic neuronsNeuroscience, 1994
- Comparison of Cardiac Pacing with Drug Therapy in the Treatment of Neurocardiogenic (Vasovagal) Syncope with Bradycardia or AsystoleNew England Journal of Medicine, 1993
- Modulatory effects of adenosine on baroreflex activation in the brainstem of normotensive ratsEuropean Journal of Pharmacology, 1989
- Cardiovascular effects of adenosine in man; possible clinical implicationsProgress in Neurobiology, 1986
- Role of cardiac vagal c-fibers in cardiovascular controlPublished by Springer Nature ,1979